Lung cancer is one of the most common types of cancer that affects millions of people worldwide. It’s a disease that can be difficult to treat, especially in its advanced stages.
One treatment option that has gained a lot of attention in recent years is Immunotherapy. But is it a last resort for lung cancer? Let’s find out.
What is Immunotherapy?
Immunotherapy is a type of cancer treatment that works by boosting the body’s immune system to fight cancer cells. The immune system is designed to defend the body against harmful invaders like viruses and bacteria. Cancer cells often evade the immune system, but immunotherapy can help activate it to recognize and attack them.
How does Immunotherapy work for Lung Cancer?
Immunotherapy can work for different types of lung cancer, including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). It Targets specific proteins on the surface of cancer cells or activates immune cells to attack them.
One type of immunotherapy called checkpoint inhibitors blocks proteins on immune cells that normally prevent them from attacking healthy cells. By blocking these proteins, these drugs help immune cells recognize and attack cancer cells.
Another type of immunotherapy involves using genetically modified T-cells to Target specific proteins on the surface of cancer cells.
Is Immunotherapy a Last Resort for Lung Cancer?
Immunotherapy is not necessarily a last resort for lung cancer, but it’s typically used after other treatments have failed or when tumors are advanced and difficult to treat with conventional therapies like chemotherapy and radiation.
It’s important to note that not all patients with lung cancer are good candidates for immunotherapy. Factors such as tumor size, location, stage, and genetic makeup can affect whether immunotherapy will be effective or not.
What are the Side Effects of Immunotherapy?
Like any other cancer treatment, immunotherapy can cause side effects. Common side effects include fatigue, fever, nausea, and loss of appetite. More serious side effects can occur as well, such as lung inflammation and autoimmune disorders.
It’s important to talk to your doctor about the potential risks and benefits of immunotherapy before starting treatment.
Conclusion
Immunotherapy is a promising treatment option for lung cancer that can help boost the body’s immune system to fight cancer cells. It’s not necessarily a last resort but is typically used after other treatments have failed or when tumors are advanced and difficult to treat with conventional therapies. It’s important to talk to your doctor about whether immunotherapy is right for you and the potential risks and benefits of this treatment.